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Abstract 
Background: Cerebral malaria (CM) is a severe neurological complication of Plasmodium falciparum infection. A 
number of pathological findings have been correlated with pediatric CM including sequestration, platelet accumula‑
tion, petechial haemorrhage and retinopathy. However, the molecular mechanisms leading to death in CM are not yet 
fully understood.
Methods: A shotgun plasma proteomic study was conducted using samples form 52 Gambian children with CM 
admitted to hospital. Based on clinical outcome, children were assigned to two groups: reversible and fatal CM. Label‑
free liquid chromatography–tandem mass spectrometry was used to identify and compare plasma proteins that were 
differentially regulated in children who recovered from CM and those who died. Candidate biomarkers were validated 
using enzyme immunoassays.
Results: The plasma proteomic signature of children with CM identified 266 proteins differentially regulated in 
children with fatal CM. Proteins from the coagulation cascade were consistently decreased in fatal CM, whereas the 
plasma proteomic signature associated with fatal CM underscored the importance of endothelial activation, tissue 
damage, inflammation, haemolysis and glucose metabolism. The concentration of circulating proteasomes or PSMB9 
in plasma was not significantly different in fatal CM when compared with survivors. Plasma PSMB9 concentration was 
higher in patients who presented with seizures and was significantly correlated with the number of seizures observed 
in patients with CM during admission.
Conclusions: The results indicate that increased tissue damage and hypercoagulability may play an important role in 
fatal CM. The diagnostic value of this molecular signature to identify children at high risk of dying to optimize patient 
referral practices should be validated prospectively.
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Background
Severe malaria (SM) is a major public health problem 
that accounts for more than 400,000 deaths each year, 
mainly in sub-Saharan Africa [1]. Cerebral malaria (CM) 
is a severe neurological complication of malaria infection 
that causes acute non-traumatic encephalopathy. Chil-
dren with CM usually present with coma and 1–4  days 
history of fever and convulsions [2]. In African children, 
petechial brain haemorrhage and retinopathy were found 
to correlate with fatality in children with CM [3]. The 
majority of the children who are admitted at an early 
stage of the disease and treated appropriately recover 
consciousness in 2–3  days. However, nearly one-fifth of 
these children develop neurological sequelae [2, 4].
The pathophysiology of CM is poorly understood 
and several mechanisms of disease have been pro-
posed [5]. Parasite sequestration and cytokine acti-
vation are the two leading hypotheses to explain CM 
pathogenesis [2, 6]. Sequestration of parasite-infected 
erythrocytes (PfIEs) obstructs brain microvasculature 
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causing hypoxia to the surrounding brain paren-
chyma and subsequent brain injury. Up-regulation of 
cytokines, mainly TNF in Gambian and Ghanaian chil-
dren was also correlated with CM [7–9]. TNF induces 
iNOS, an enzyme which produces nitric oxide, a free 
radical that modifies brain signaling and electrolyte 
physiology [10].
The function of the vascular endothelium is intrinsi-
cally linked to the coagulation cascade, and any biologi-
cal or pathological change of the former will necessarily 
disrupt the function of the latter. Indeed, dysregula-
tion of the coagulation cascade has been observed in 
CM [11]. Upregulation of endothelial and platelet-
derived micro-particles with increased adhesiveness 
of endothelial cell-leukocyte-platelet interaction was 
shown in children with CM. In addition, platelet adhe-
sion and aggregation are involved in cytoadhesion of 
PfIEs [12, 13] and in modulating sequestration [14]. 
Furthermore, the severity of CM in children was cor-
related with the inhibition of ADAMTS13 and thus 
with an increase of abnormal circulating ultra large von 
Willebrand factor (ULVWF) multimers that cross-link 
platelets, induce thrombocytopaenia [5] and enhance 
obstruction of the brain microvasculature [15, 16]. 
More recently, the role of the endothelial protein C 
receptor (EPCR) has been reported as a major biologi-
cal player in Plasmodium falciparum CM [17].
Tissue damage is an inevitable consequence of any 
severe infection, particularly when oxygen supply to 
peripheral tissues is compromised by vascular obstruc-
tion. The role of muscle damage during the course of 
CM has been recently inferred from a strong signature 
of muscle proteins in plasma from CM patients [18]. 
However, it remains unclear if this signature derives 
from microvascular lesions in the muscle or from mus-
cle tissue damage associated with the seizing activity 
frequently observed in patients with CM [19]. High 
levels of 20S proteasomes in human serum, conven-
tionally called circulating proteasomes, are increased 
in patients with conditions such as sepsis and malig-
nancies [20], usually associated with tissue damage and 
muscle wasting. This process is critical in severe infec-
tion and other hypercatabolic states that result in high 
protein turnover [21].
Discovery proteomics using tandem mass spectrom-
etry is increasingly being used to investigate changes in 
the proteome of specific physiological compartments, 
which often capture disease-specific changes of clinical 
relevance [22]. To better understand the disease mecha-
nism associated with fatal CM and with a view to identify 
prognostic markers, a shotgun proteomic analysis was 
conducted to compare the plasma proteomic signature of 
children with CM that survived and those that died.
Methods
Clinical study
EDTA-plasma samples were collected from children 
aged 4  months to 14  years admitted to the Royal Vic-
toria Teaching Hospital (RVTH) in Banjul, the main 
health facility in The Gambia, from January 1997 to 
December 2009 [23]. All patients included in the study 
had a blood smear positive for asexual P. falciparum 
parasites and met one or more of the WHO criteria 
for severe malaria [19]. Samples were collected before 
patients were transfused. Non-survivor patients are 
those who died within 48  h of admission. CM was 
defined as a Blantyre coma score of 2 or less with any 
P. falciparum parasite density. The coma score was car-
ried out at least 30 min after the last seizure and after 
correction of hypoglycaemia, and at least 6  h after 
treatment of seizures with anticonvulsants.
Sample preparation
Samples were selected and separated by phenotype 
(CM dead–CM alive) and three pools of samples per 
group were generated prior to analysis. The 14 most 
abundant human plasma proteins were depleted using 
the Agilent Multiple Affinity Removal Spin Cartridge 
System (Agilent) according to the manufacturer’s 
instructions. Briefly, human plasma samples were cen-
trifuged at 12,000g for 10  min to remove any precipi-
tates and particles, then 10  µl of plasma were further 
diluted with 200  µl of buffer A and filtered through 
0.22-µm spin filter. The spin cartridge was flushed with 
2 ml of Buffer A (Agilent), next 200 µl of diluted plasma 
sample were loaded to the cartridge and spun at 100×g 
for 1.5  min and the flow-through containing remain-
ing plasma proteins was then collected. The cartridge 
was washed with 400 µl of Buffer A and spun at 100×g 
for 2.5 min. The wash step was repeated twice. Finally, 
the bound top 14 proteins were eluted by adding 2 ml 
of buffer B (Agilent) followed by re-equilibration with 
4 ml of Buffer A before the next run.
Top 14-depleted plasma samples were further con-
centrated and desalted by TCA/DOC precipitation. 
Sodium deoxycholate (final concentration: 125  µg/
ml) was added to the samples, vortexed, and left for 
15 min at RT. Trichloroacetic acid (final concentration: 
6%) was then added and the samples were centrifuged 
for 10  min at 12,000g. The pellet was washed in 100% 
ice-cold acetone and centrifuged at 10,000g for 5  min 
at 4  °C. The supernatant was discarded and the dried 
pellet was resuspended in 50 µl of buffer containing 
6 M Urea and 100 mM Tris. Protein concentration was 
quantified using BCA assay (Thermo).
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SDS‑PAGE and protein digestion
For each sample, 200 μg of proteins were resuspended in 
200 μl with 1X Laemmli buffer and 20 μl loaded onto a 
criterion XT Bis–Tris gel 4–12% using 1X XT MES run-
ning buffer (Bio-Rad). The gels were stained with Instant 
Blue (Expedeon Ltd, Harston, UK) for 10 min and trans-
ferred in distilled water for direct use. For each sample, 
15 bands were excised, washed in 50% ethanol 5% acetic 
acid, and dehydrated in acetonitrile (ACN). Gel pieces 
were treated with 10 mM DTT and 50 mM IAA, dehy-
drated with ACN, dried completely, rehydrated with 
100  mM  NH4HCO3 then dehydrated again and dried. 
Dried gel pieces were then incubated overnight at 37 °C 
with 60  ng trypsin (Promega) in 50  mM  NH4HCO3. 
Peptides were then extracted with buffer B (85% ACN, 
5% formic acid (FA)), dried down completely and resus-
pended in buffer A (2% ACN, 0.1% FA). Digested peptides 
were purified using SEP-PACK C18 column (Waters) and 
eluted with 0.6 ml buffer B (65% HPLC grade ACN and 
0.1% FA) twice. Purified peptides were then completely 
vacuum dried in speed-vac (Thermo) and resuspended in 
100 µl of Buffer A (2% ACN, 0.1% FA).
Mass spectrometry analysis
Nano-LC–MS/MS analysis was performed using 
100  µm-inner diameter × 10  cm C18 column (Proxeon) 
on a 90  min gradient of 2–42% solvent B (solvent A: 
99.9%  H2O, 0.1%  FA; solvent B: 99.9% ACN, 0.1% FA). 
Two technical replicates per sample were analysed in 
positive mode using 1 μg of peptides per sample per run. 
The nano-LC system (final rate 0.25 μl/min) was coupled 
to a LTQ-Orbitrap Velos (Thermo) as described previ-
ously [24]. MS scans were performed with a mass range 
of 300–1600 (m/z) and a mass resolution of 60,000, ana-
lysing the top 20 precursor ions using collision induced 
dissociation (CID) mode in the Iontrap at collision energy 
of 35 V and dynamic peak exclusion duration of 20 s.
Database searching and label‑ free protein quantitation
MS/MS spectra were extracted from raw files using 
Proteome Wizard MSConvert (Thermo) using the 
200 most intense peaks in each spectrum and con-
verted into MGF-format peaklists. The peaklists were 
searched against the “in-house” customized database 
for human plasma (human and P. falciparum sequences, 
humanIPI3.75_falciparum3D7) using the central prot-
eomics facilities pipeline CPFP that combines data from 
three search engines (Mascot, OMSSA and X!tandem 
k-score) [25, 26]. Searches were performed using the 
following parameters: digestion enzyme, trypsin; fixed 
modification, carbamidomethylation of cysteine; vari-
able modifications, oxidation of methionine and lysine 
and deamidation of asparagine and glutamine; peptide 
tolerance,  20  ppm;  fragment tolerance, 0.5  Da; missed 
cleavages. (1) Similar proteins were grouped and only 
non-conflicting features (peptide spectrum matches) 
were used for quantitation. The label-free analysis was 
carried out using the normalized spectral index SINQ 
[25].
Immunoassays
Plasma levels of circulating proteasomes (20S) and 
PSMB9 were measured using a double antibody sand-
wich Enzyme-Linked Immunosorbent Assay (Antibod-
ies-online Inc.). Assays were performed according to 
manufacturer’s instructions.
Results
Identification of proteomic markers associated with fatal 
outcome in cerebral malaria
In this study, 52 Gambian children with CM were 
included. Of these, 26 died and 26 survived. The only 
clinical feature that was significantly different between 
the survivors of CM and those with a fatal outcome was 
the presence of respiratory distress in those who died 
(P = 0.002). Parasite density and haemoglobin concen-
tration were higher in patients who died, but these dif-
ferences were of borderline statistical significance. The 
main clinical features of the two groups are described in 
Table 1.
The plasma proteome of 52 Gambian children with CM 
was characterized using a shotgun proteomic approach. 
A total of 6296 peptides corresponding to 504 proteins 
were identified, 392 in children who survived and 456 in 
children who died (Fig. 1a, b). Accordingly, 266 proteins 
were identified as differentially expressed. Of these, 196 
were up-regulated in children who died compared to 70 
that were up-regulated in survivors (Fig. 1c).
Host and parasite pathological modules associated 
with fatal outcome in cerebral malaria
A complex proteomic signature was found to be associ-
ated with CM. A number of host and parasitic protein 
signatures were associated with a fatal outcome including 
endothelial activation, depletion of coagulation factors, 
activation of acute-phase reaction, glucose metabolism 
and tissue damage (represented by high levels of protea-
some subunits) (Fig. 2 and Additional file 1). More spe-
cifically, these data confirm the role of three cell adhesion 
molecules (CAMs), VCAM-1, ICAM-1 and ICAM-2 in 
the pathophysiology of CM infection, all of them up-reg-
ulated in fatal cases. In addition, immunoglobulin J-chain 
and profilin-1, two of the ten most abundant micropar-
ticle (MP) proteins, were found to be decreased in fatal 
cases.
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Plasmodium falciparum parasite proteins were also 
detected and all were consistently higher in fatal cases, 
probably indicating an association of poor clinical 
outcome with higher parasite densities and increased 
sequestration in brain microvasculature. Of these pro-
teins, four enzymes are included in the glycolytic 
Table 1 Properties of the study population as reported/measured in individual cases
a Deep coma was defined as a Blantyre Coma score of 0 or 1. Respiratory distress was defined as the presence of deep breathing, irregular breathing, or chest 
in-drawing
Survived (N = 26) Died (N = 26) P value
Sex (male/female) 14/15 15/9 0.33
Age (median, IQR) months 60 (35–95) 48 (24–83) 0.32
Hb (mean, SD) g/dl 7.27 (1.93) 8.03 (2.15) 0.07
Respiratory  distressa (%) 24.1 66.6 0.002
Convulsions on admission (%) 75 69.2 0.77
Deep coma (%)a 31 54 0.08
Transfused (%) 37.9 45.8 0.56
P. falciparum (geo mean, 95% CI) parasites/µl 35,341 (18,759–66,581) 55,792 (28,797–108,095) 0.051
Protein biomarkers
 Circulating 20S proteasomes (ng/ml) 39.4 (19.6–49.4) 22.7 (16–34.5) 0.20
 PSMB9 (ng/ml) 177 (129–267) 209 (161–271) 0.49
Fig. 1 Plasma proteome profile of Gambian children with CM. a Heat map of the normalized protein quantitation value of detected plasma 
proteins according to the color scale at the bottom. Each row represents a protein. b Venn diagram indicates the total number of proteins identified 
and shows the unique proteins identified in pooled plasma samples of survivors and fatal cases and proteins identified in both groups. c Frequency 
distribution of the relative quantitation values of proteins in the plasma of survivors compared to fatal cases. Sur survivors, FC fatal cases
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pathway, two enzymes in the purine salvage pathway, and 
one protein derives from the parasite’s cell membrane.
High levels of 20S proteasome subunits and PSMB9 
in plasma are associated with seizures in CM in children 
but not with death
A number of proteasome subunits were identified in 
patients with CM with a fatal outcome. It was hypoth-
esized that this was consistent with an increase in circu-
lating 20S proteasome subunits in fatal cases, probably 
resulting from ongoing cytolysis and tissue damage of 
undetermined origin (Fig. 2 and Additional file 1). How-
ever, the concentration of circulating proteasomes meas-
ured in individual samples was not significantly different 
between children with CM who survived and those who 
died (Additional file 2).
A similar analysis was then conducted measur-
ing PSMB9 in individual patients because this marker 
showed the highest and most significant difference across 
groups. The concentration of PSMB9 was significantly 
different in patients with CM who died and those who 
survived. However, both circulating 20S proteasomes and 
PSMB9 were higher in those patients with CM who pre-
sented with convulsions during admission. Interestingly, 
PSMB9 was positively correlated with the number of wit-
nessed seizure in patients with CM (r = 0.45, P = 0.01) 
(Additional file 2).
Depletion of coagulation factors is associated with death
Of thirteen proteins involved in the coagulation cascade, 
eleven were down-regulated in fatal cases. Factors V and 
X, the main factors mediating prothrombin degradation 
on the activated platelet surface, were down-regulated in 
fatal cases. Of the intrinsic pathway proteins, factors IX 
and XII were down-regulated in fatal cases, whereas fac-
tor XI and kininogen-1 were up-regulated. Prothrombin 
(factor II) and fibrinogen were down regulated in fatal 
cases. Antithrombin III (Serpin C1) and heparin cofactor 
II (Serpin D1), both major thrombin inhibitors, were also 
down-regulated. Alpha-1 antitrypsin (Serpin A1: known 
to down-regulate factor XI) and plasminogen activator 
inhibitor-1 (PAI-1 or Serpin E1: inhibitor of tissue plas-
minogen activator and urokinase), were also decreased in 
fatal cases.
Fig. 2 Proteomic signatures associated with pediatric fatal CM. Data show fold change in protein abundance as the ratio of proteomic 
quantification using SINQ values [25] in the fatal CM plasma pool to that in the reversible CM pool. Red indicates proteins increased in fatal CM 
cases and green indicates proteins increased in CM survivors. Dashed line indicates 1.5‑fold‑change in protein abundance
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Discussion
In this study, a comprehensive proteome characterization 
of plasma samples obtained from children with CM that 
survived is reported, and is compared with the signature 
of those who died. Here protein changes in three major 
pathobiological modules activated in fatal cases of CM is 
reported, namely (1) endothelial activation and inflam-
mation, (2) circulating proteasomes possibly reflecting 
tissue damage and (3) depletion of proteins of the coagu-
lation cascade. These biological signatures support cur-
rent understanding of the pathogenesis of CM and show 
a novel association of the PSMB9 proteasome protein 
with the number of seizures witnessed in patients admit-
ted to hospital with CM.
The findings in this study support the critical role of 
the vascular system in the pathogenesis of CM. During 
P. falciparum malaria infection, coagulation is activated 
as a result of cytokine-mediated endothelial activation, 
increased circulating endothelial and platelet-derived 
microparticles, and/or platelet adhesion to endothelium 
[11]. TNF-mediated upregulation of endothelial ICAM-1 
enhances platelet adhesion to brain endothelial cells. 
Experimental models showing that ICAM-1 knockout 
mice are resistant to CM also support this finding [27]. 
In this study, ICAM-1, ICAM-2 and VCAM-1 were up-
regulated in fatal cases, indicating that endothelial activa-
tion is associated with poor clinical outcome.
Vascular activation and inflammation are biologi-
cally linked and inflammatory cytokines are a key player. 
Indeed, CM has been associated with high concentra-
tions of IL-6, IL-10, and TNF in plasma [2]. However, 
these cytokines circulate at very low concentrations (pg/
ml to low ng/ml) in plasma. Despite extensive depletion 
of highly abundant proteins in combination with protein 
gel fractionation, our study failed to identify and quan-
tify low abundant cytokines. Based on previous MS/MS 
quantification studies of P. falciparum proteins in these 
plasma samples [28], it is estimated that the LC–MS/MS 
workflow used here can identify and quantify proteins 
that circulate at concentrations of 100  ng/ml or higher. 
Therefore, low abundance cytokines like TNF, IL-10 or 
gamma-interferon could not be identified. Similarly, 
other important molecules like angiopoietins could not 
be identified in this study. The role of angiopoietins in 
the pathogenesis of CM has been reported both in chil-
dren and adults with CM. These proteins capture disrup-
tive changes of the vascular homeostasis which possibly 
result from P. falciparum-induced changes in endothelial 
cells. Indeed, the ratio of angiopoietin-1 to angiopoi-
etin-2 has been proposed as a potential marker of severe 
malaria with prognostic value [29, 30]. The concentration 
of angiopoietins in plasma of CM patients is typically 
lower than 100 ng/ml, below the concentration range of 
proteins susceptible to be identified by our shotgun pro-
teomic approach. Although the study was limited in the 
proteomic dynamic range explored using LC–MS/MS, 
other inflammatory mediators such as acute-phase pro-
teins and complement were prominent in the signature of 
children with CM who died.
The role of the coagulation cascade in the con-
text of endothelial activation has acquired increasing 
importance in the pathogenesis of CM in recent years. 
Increased circulatory levels of the glycoprotein von 
Willebrand factor (vWF) has been associated with fatal 
CM, usually accompanied by a significant reduction 
of the plasma ADAMTS13 enzyme [11, 16]. Plasmo-
dium falciparum parasites causing severe malaria have 
a stronger affinity for endothelial protein C receptor 
(EPCR) than parasites from children with uncomplicated 
malaria. Consequently, malaria-induced decrease of 
EPCR impairs the protein C system causing a sustained 
pro-coagulant state in the brain microvasculature [17, 
31]. The data support a non-specific consumption and 
consequent depletion of coagulation proteins in children 
with CM who died compared with those that survived 
(outlined in Fig.  3). The majority of depleted coagula-
tion factors that were identified belonged to the intrin-
sic pathway, which is triggered by endothelial activation. 
Similarly, downstream coagulation factors leading to clot 
formation (prothrombin and fibrinogen) and thrombin 
inhibitors like antithrombin-III (AT-III, SerpinC1) and 
heparin cofactor II (Serpin D1) were also decreased in 
fatal cases. Although these findings are compatible with 
a systemic activation of the coagulation system and pos-
sibly with disseminated intravascular coagulation, this 
diagnosis could not be formally ascertained in these 
patients.
Tissue damage is a prominent feature of CM and any 
other infection severe enough to compromise vascular 
flow and consequently oxygen delivery to cells. The 
role of muscle damage has been recently highlighted in 
a prospective study of CM in Nigerian children [18]. 
Therefore, it was hypothesized that the detection of 
increased levels of proteasomal proteins in plasma was 
possibly attributable to cell lysis in response to tissue 
hypoxia. Notably, all 20S proteasome subunits were 
consistently elevated in the plasma of fatal cases when 
compared with survivors. Circulating 20S proteas-
omes levels have been shown to increase in the sera 
of septic patients and in a number of haematopoietic 
and solid tumours indicating tissue damage [20, 32]. 
Erythrocytes are another potential source of human 
20S proteasomes [33]. Consequently, ongoing haemol-
ysis induced by red cell lyses of parasitized cells could 
account for this observation. However, haemolysis 
induces a major depletion of haptoglobin from plasma, 
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which was not observed in fatal cases. It was, there-
fore, concluded that red cells were an unlikely source 
of proteasomes in these patients.
In contrast, total circulating proteasomes as meas-
ured by ELISA were higher in patients that survived. 
While these could be “transition states” towards form-
ing the intact 20S, to the best of the authors knowl-
edge it is not clear whether individual subunits may 
have distinct biological roles. Indeed, 20S proteas-
omes and PSMB9 were higher in those children with 
CM who presented with convulsions during admis-
sion to hospital. Interestingly, PSMB9 but not circu-
lating 20S proteasomes were significantly correlated 
with the number of seizures witnessed during hos-
pital admission. The biological significance of these 
finding remains unclear. The authors speculate that 
these proteasomes might originate from tissue dam-
age that results from acute muscle contraction during 
seizing activity in children with CM. This hypothesis 
should be tested in prospective clinical studies for 
confirmation.
Conclusion
An unbiased plasma proteomic study was conducted 
to identify proteins associated with a poor outcome in 
CM. This study not only supports the role of endothelial 
activation, tissue damage and the coagulation cascade 
in the pathogenesis of CM, but also highlights the prog-
nostic importance of these pathobiological modules. In 
addition, these data show the association of higher levels 
of circulating proteasomes with seizures. The origin of 
these proteasomal proteins and their clinical significance 
are currently under study.
Additional files
Additional file 1. List of differentially expressed proteins in fatal CM cases 
as measured by LC‑MS/MS analysis.
Additional file 2. Circulating proteasomes and PSMB9 in patients with 
cerebral malaria. Dot plots show the concentration of total circulating 20S 
proteasomes (left panels) and PSMB9 (right panels) in children with CM 
based on outcome (top), presence of seizures during admission (middle) 
and the correlation of these biomarkers with the number of seizures 
witnessed during admission (bottom).
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